Prague, Czechia

Tomas Gurgut


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tomas Gurgut in Pharmaceutical Chemistry

Introduction

Tomas Gurgut is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have led to advancements that benefit the medical community.

Latest Patents

Tomas Gurgut holds a patent for "Crystalline modifications of methyl (3Z)-3-{[(4-{methyl[(4-methylpiperazin-1-yl)acetyl]amino}phenyl)amino](phenyl)methylidene}-2-oxo-2,3-dihydro-1H-indole-6-carboxylate salts and methods of preparation thereof." This patent involves crystalline modifications of specific compounds, which are crucial for developing pharmaceutical compositions. The compounds are designed to enhance the efficacy of treatments and provide new avenues for drug formulation.

Career Highlights

Tomas Gurgut is currently associated with Zentiva a.s., a prominent company in the pharmaceutical industry. His work at Zentiva has allowed him to collaborate with other talented professionals and contribute to groundbreaking research. His patent reflects his commitment to innovation and the advancement of pharmaceutical sciences.

Collaborations

Tomas has worked alongside esteemed colleagues such as Eszter Tieger and Marcela Tkadlecova. Their collaborative efforts have fostered a productive research environment, leading to significant advancements in their field.

Conclusion

Tomas Gurgut's contributions to pharmaceutical chemistry through his innovative patents exemplify the impact of dedicated research in the medical field. His work continues to inspire future innovations and advancements in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…